-
Pfizer’s PF-06939926 Shows Promise for Treating Duchenne MD
Preliminary findings from a Phase 1b trial show that Pfizer’s PF-06939926 demonstrated promising safety and efficacy results in the treatment of DMD. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.